Chlamydia Infection Diagnostics and Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Chlamydia Infection Diagnostics and Therapeutics Market By diagnostics (Direct Fluorescent Tests, Nucleic Acid Amplification Tests, Others), by therapeutics ( Antibiotics (Tetracyclines, Macrolides, Quinolones) Others), by end user (Hospitals and Hospital Pharmacies, Retail Pharmacies, Others) Geography.

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Chlamydia Infection Diagnostics And Therapeutics Market size was valued at USD 2.6 billion in 2021 and is expected to reach USD 3.9 billion by 2028, at a CAGR of 6.1% during the forecast period 2022-2028. Chlamydia is a sexually transmitted disease (STD) caused by the bacteria Chlamydia trachomatis, and it can be transmitted to baby at birth. chlamydia infection diagnostics and therapeutics market usually doesn’t have any symptoms but often infected may have symptoms such as genital pain and genital discharge both in men and women. Furthermore, chlamydia infection can cause health complications such as preventing women from getting pregnant or even endangering their pregnancies. Some people may experience pain in lower abdomen, pelvis, testicle or vagina and may also have eye discharge or spotting. Treatment may include antibiotics, anti-inflammatory agents, and hospital stay may be required. Global chlamydia infection diagnostics and therapeutics market is growing at significant rates owing to prevalence rate of sexually transmitted diseases. According to World Health Organization (WHO), worldwide, more than one million sexually transmitted infections are acquired every day. Each year, an estimate of 131 million new cases of chlamydia infection are reported. Companies are focusing on the development of the new ways to detect chlamydia infection in initial stages. For instance, in December 2016,  F. Hoffmann-La Roche AG launched cobas 6800/8800 systems for detection of Chlamydia trachomatis and Neisseria Gonorrhoea (NG) DNA.

Chlamydia Infection Diagnostics And Therapeutics Market

MARKET SUMMARY
-
6.1%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.1%
  • Largest Market– Europe
  • Fastest Growing Market– North-America

Chlamydia Infection Diagnostics And Therapeutics

  • This report gives a comprehensive outlook on chlamydia infection diagnostics and therapeutics across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa.
  • The chlamydia infection diagnostics and therapeutics market report gives historical, current, and future market sizes (US$ Mn) on the basis of diagnostics, therapeutics, end user and region.
Key Players
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Becton Dickinson and Company
  • bioMérieux
  • DiaSorin SpA
Chlamydia Infection Diagnostics And Therapeutics Market

DRIVERS AND RESTRAINTS

Global chlamydia infection diagnostics and therapeutics market is mainly driven by an increase in prevalence of sexually transmitted diseases worldwide. Furthermore, emergence of rapid test and advances in biotechnology are expected to boost the chlamydia infection diagnostics and therapeutics market. In addition, increase in R&D activities towards development of therapeutics for antibiotic-resistant bacteria and initiatives by government and non-government agencies (such as World Health Organization (WHO) to increase awareness about STD’s and their symptoms are expected to bolster the chlamydia diagnostics and therapeutics market during the forecast period. However, high cost of development, stringent regulatory procedures for the approval and bacterial drug resistance is expected to hamper the chlamydia infection diagnostics and therapeutics market.


North-America Got Significant Share

Chlamydia Infection Diagnostics And Therapeutics Market

Geographically, chlamydia infection diagnostics and therapeutics market is segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America market is expected to grow at significant rates owing to well-established healthcare infrastructure, presence of more number of market players and increase in awareness in related to early detection and treatment of sexually transmitted diseases. According to Centre for Disease Control and Prevention (CDC) in 2014, a total number of 1,441,789 chlamydia infections were reported to CDC in 50 states and District of Columbia in the United States. Europe chlamydia infection diagnostics and therapeutics market is expected to grow at notable rates owing to factors such as developed healthcare infrastructure and growing awareness related to STI’s. Asia Pacific market growth is attributed to developing infrastructure and prevalence of the chlamydia sexually transmitted diseases. According to World Health Organization, “Global incidence and prevalence of selected curable sexually transmitted infections – 2008”, in South East Asia region estimated that 8 million adults were infected with Chlamydia in 2008.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Developments

  • In October 2016, Becton Dickinson and Company (BD) received U.S. FDA approval for BD Max Vaginal Panel, for detection of most common causes of vaginal infections including chlamydia trichomoniasis.

Key

Features of the Report

Chlamydia Infection Diagnostics And Therapeutics Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

    1. Table of Content
    2. Executive Summary
    3. Global Chlamydia Infection Diagnostics and Therapeutics Market Introduction
      • Global Chlamydia Infection Diagnostics and Therapeutics Market – Taxonomy
      • Global Chlamydia Infection Diagnostics and Therapeutics Market –Definitions
        • Diagnostics
        • Therapeutics
        • End User
    1. Global Chlamydia Infection Diagnostics and Therapeutics Market Dynamics
      • Drivers
      • Restraints
      • Opportunities/Unmet Needs of the Market
      • Trends
      • Global Chlamydia Infection Diagnostics and Therapeutics Market Dynamic Factors – Impact Analysis
      • Global Chlamydia Infection Diagnostics and Therapeutics Market – Competition Landscape
      • Epidemiology
    2. Global Chlamydia Infection Diagnostics and Therapeutics Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Market OpportunityAnalysis
    3. Global Chlamydia Infection Diagnostics and Therapeutics Market, By Diagnostics, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Direct Fluorescent Tests
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Nucleic Acid Amplification Tests
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global Chlamydia Infection Diagnostics and Therapeutics Market Forecast, By Therapeutics,2015 – 2019 and Forecast, 2020 – 2026
      • Antibiotics
        • Tetracyclines
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Macrolides
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Quinolones
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
          • Others
    1. Global Chlamydia Infection Diagnostics and Therapeutics Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Hospitals and Hospital Pharmacies
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Retail Pharmacies
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global Chlamydia Infection Diagnostics and Therapeutics Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • North America
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Europe
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Asia-Pacific
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Latin America
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Middle East and Africa
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Global Chlamydia Infection Diagnostics and Therapeutics Market – Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Region, 2020 – 2026
    2. North America Chlamydia Infection Diagnostics and Therapeutics MarketAnalysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Diagnostics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • U.S.
        • Canada
      • North America Chlamydia Infection Diagnostics and Therapeutics Market – Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2020 – 2026
      • North America Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    3. Europe Chlamydia Infection Diagnostics and Therapeutics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Diagnostics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Chlamydia Infection Diagnostics and Therapeutics Market – Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2020 – 2026
      • Europe Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    4. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Diagnostics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Japan
        • China
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of Asia-Pacific
      • Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market – Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2020 – 2026
      • Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    5. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Diagnostics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Venezuela
        • Rest of Latin America
      • Latin America Chlamydia Infection Diagnostics and Therapeutics Market – Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2020 – 2026
      • Latin America Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    6. Middle East and Africa Chlamydia Infection Diagnostics and Therapeutics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Diagnostics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Chlamydia Infection Diagnostics and Therapeutics Market – Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2020 – 2026
      • MEA Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    7. Competition Landscape
      • Strategic Dashboard of Top Market Players
      • Company Profiles (Introduction, Financial Analysis, Diagnostics& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
        • Novartis AG (Switzerland)
        • Bio-Rad Laboratories Inc. (U.S.)
        • Hoffmann-La Roche AG (Switzerland)
        • The Danaher Corporation (U.S.)
        • Abbott Laboratories (U.S.)
        • bioMérieux (France)
        • Siemens AG (Germany)
        • DiaSorin SpA (Italy)
        • Becton Dickinson and Company (U.S.)
        • Thermo Fisher Scientific (U.S.)
    1. Research Methodology
    2. Key Assumptions and Acronyms

     

    1. Disclaimer The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

Report

Company Profile

  • Novartis AG (Switzerland)
  • Bio-Rad Laboratories Inc. (U.S.)
  • F. Hoffmann-La Roche AG (Switzerland)
  • The Danaher Corporation (U.S.)
  • Abbott Laboratories (U.S.)
  • BioMérieux (France)
  • Siemens AG (Germany)
  • DiaSorin SpA (Italy)
  • Becton Dickinson and Company (U.S.)
  • Thermo Fisher Scientific (U.S.)

Description

Chlamydia Infection Diagnostics And Therapeutics Market size was valued at USD 2.6 billion in 2021 and is expected to reach USD 3.9 billion by 2028, at a CAGR of 6.1% during the forecast period 2022-2028. Chlamydia is a sexually transmitted disease (STD) caused by the bacteria Chlamydia trachomatis, and it can be transmitted to baby at birth. chlamydia infection diagnostics and therapeutics market usually doesn’t have any symptoms but often infected may have symptoms such as genital pain and genital discharge both in men and women. Furthermore, chlamydia infection can cause health complications such as preventing women from getting pregnant or even endangering their pregnancies. Some people may experience pain in lower abdomen, pelvis, testicle or vagina and may also have eye discharge or spotting. Treatment may include antibiotics, anti-inflammatory agents, and hospital stay may be required. Global chlamydia infection diagnostics and therapeutics market is growing at significant rates owing to prevalence rate of sexually transmitted diseases. According to World Health Organization (WHO), worldwide, more than one million sexually transmitted infections are acquired every day. Each year, an estimate of 131 million new cases of chlamydia infection are reported. Companies are focusing on the development of the new ways to detect chlamydia infection in initial stages. For instance, in December 2016,  F. Hoffmann-La Roche AG launched cobas 6800/8800 systems for detection of Chlamydia trachomatis and Neisseria Gonorrhoea (NG) DNA.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX